NA Semax Amidate
Enhanced Nootropic Peptide | Cognitive Enhancement & Neuroprotection
N-Acetyl Semax Amidate is an enhanced and stabilized version of the Russian nootropic peptide Semax. Through acetylation and amidation modifications, it achieves superior stability, extended half-life, and enhanced bioavailability compared to standard Semax. This synthetic analog of ACTH (4-10) is designed for advanced cognitive enhancement and neuroprotection research.
Daily dose
600-1200μg
Frequency
1-2x daily
Cycle length
10-30 days
Storage
2-8°C
Key benefits
Enhanced cognitive function, improved memory formation, neuroprotective effects, extended half-life, superior stability, research-validated efficacy
How it works
NA Semax Amidate works by rapidly increasing BDNF and TrkB expression in the hippocampus, activating serotonergic and dopaminergic systems, and potentially modulating melanocortin receptors to enhance neuroplasticity and cognitive function
Dosage protocols
Goal
Cognitive enhancement
Dose
600μg · 1x daily
Route
Intranasal spray
Goal
Mental fatigue resistance
Dose
800μg · 1x daily
Route
Intranasal spray
Goal
Memory enhancement
Dose
600μg · 2x daily
Route
Intranasal spray
Goal
Neuroprotection
Dose
1200μg · 1x daily
Route
Intranasal spray
Research indications
cognitive
neuroprotection
memory
Administration
Interactions
Safety notes
Use only sterile, pharmaceutical-grade solutions for nasal administration
Start with lower doses to assess individual tolerance and response
Avoid use if nasal congestion or active sinus infection present
Monitor for any unusual nasal irritation or allergic reactions
Not recommended during pregnancy or breastfeeding
Consult healthcare provider if taking medications affecting neurotransmitters
Research studies
Default Mode Network Enhancement (2018)
24 participants | 1% solution intranasal | fMRI monitoring | DMN volume increase
fMRI study demonstrated Semax significantly increased volume in the rostral subcomponent of the default mode network, particularly in medial frontal cortex, enhancing episodic memory and information processing.
Stroke Recovery and BDNF Enhancement (2018)
110 stroke patients | 10-day treatment protocol | BDNF level monitoring | Motor function improvement
Clinical trial in stroke patients showed Semax administration increased brain-derived neurotrophic factor levels and accelerated functional recovery during rehabilitation.
Gene Expression and Neuroprotection (2014)
Rat model | Genome-wide analysis | 3-24 hour timepoints | 96+ gene expression changes
Comprehensive genome-wide study revealed Semax affects expression of genes related to immune response, vascular function, and neuroprotection in brain ischemia models.
Cognitive Enhancement in Fatigued Subjects (1996)
Human study | 250-1000μg intranasal | 24-hour effects | 71% vs 41% memory accuracy
Landmark study showing Semax improved attention and short-term memory in healthy subjects during 8-hour work shifts, with pronounced effects when fatigued and lasting benefits into the next day.